Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1996
12/31/1996US5589338 Nucleic acids encoding a mutant form of human serum albumin involved in familial dysalbuminemic hyperthyroxinemia
12/31/1996US5589185 Nonsteroidal antiinflammatory agents
12/31/1996US5589184 Pharmaceutical compositions and methods of treatment of the cornea following laser treatment
12/31/1996US5589174 Anti-human influenza virus antibody
12/31/1996US5589173 Anticoagulants
12/31/1996US5589171 Treatment of Dupuytren's disease with collagenase
12/31/1996US5589170 Antiinflammatory agent
12/31/1996US5589169 Topical application of tissue plasminogen activator
12/31/1996US5589167 Excipient stabilization of polypeptides treated with organic solvents
12/31/1996US5589154 Diagnosing presence of b-amyloid peptide
12/31/1996US5588422 Methods and pharmaceutical compositions for enhanced cardiopulmonary resuscitation
12/31/1996CA2180280A1 Adenyl-cyclase-hemolysin (ac-hly)-protecting epitopes; use thereof for the treatment or the prevention of infections by bordetella
12/31/1996CA2019745C Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same
12/31/1996CA1338824C Hypoglycemic and growth-promoting agent isolated from bacitracin
12/31/1996CA1338818C Immunotoxins
12/29/1996CA2180193A1 Enhancing host immunity against viral infections
12/29/1996CA2180079A1 Use of balhimycin as production promoter in animals, and production promoter compositions
12/27/1996WO1996041887A1 Dnase-active protein
12/27/1996WO1996041883A1 Plasmin-resistant streptokinase
12/27/1996WO1996041880A1 Adherence gene from helicobacter pylori and polypeptide coded thereby
12/27/1996WO1996041878A1 Nucleic acid molecule and its uses in determining pathogenicity of staphylococcus
12/27/1996WO1996041870A1 Hydrosoluble compositions of stabilized collagenase and the process for their preparation
12/27/1996WO1996041868A2 Prothrombin derivatives
12/27/1996WO1996041818A1 Chitin hydrogels, methods of their production and use
12/27/1996WO1996041816A1 Factor ix binding peptides, derived from factor viii and their use as inhibitors of blood coagulation
12/27/1996WO1996041815A2 CONJUGATES OF αMSH WITH A FATTY ACID, PREPARATION METHOD THEREFOR, AND USE THEREOF AS A DRUG
12/27/1996WO1996041814A1 Peptide, bronchodilator and blood flow ameliorant
12/27/1996WO1996041644A1 Oral remedy for rheumatoid arthritis and functional food
12/27/1996WO1996041643A1 Antiviral method and antiviral agent
12/27/1996WO1996041642A1 Stable freeze-dried composition containing tpo
12/27/1996WO1996041641A1 Pharmaceutical compositions with analgesic activity
12/27/1996WO1996041640A1 Bradykinin analogs as selective thrombin inhibitors
12/27/1996WO1996041639A1 Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells
12/27/1996WO1996041638A1 Calpain inhibitors for the treatment of neurodegenerative diseases
12/27/1996WO1996041624A1 TNF-α CONVERTING ENZYME
12/27/1996WO1996041620A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells
12/27/1996WO1996041609A2 Methods and compositions for stimulating neurite growth
12/27/1996WO1996041607A2 Pharmaceutical compositions comprising restrictin p/activin a and use thereof as antagonist of il-6 and/or il-11
12/27/1996WO1996041523A1 Fgf9 as a specific ligand for fgfr3
12/27/1996WO1996035784A3 Chromatin-regulator genes
12/27/1996WO1996035715A3 Pcna binding substance
12/27/1996WO1996031607A3 Use of an 'immunodeficiency-virus suppressing lymphokine (isl)' to inhibit the replication of viruses, in particular of retroviruses
12/27/1996WO1996031525A3 Inhibitors of farnesyl-protein transferase
12/27/1996WO1996030395A3 Cysteine protease inhibitor
12/27/1996WO1996021731A3 Stabilized external guide sequences
12/27/1996EP0750044A2 DNA constructs and transfection of cells therewith for homologous recombination
12/27/1996EP0750039A1 Immunoregulatory protein LST-1
12/27/1996EP0750038A2 A mutant gene causing a defect in mitochondrial recombination and a method for its detection
12/27/1996EP0750037A2 TNF-convertase and method measuring inhibition of TNF convertase
12/27/1996EP0749979A2 Method and composition for treating thrombosis
12/27/1996EP0749582A1 Methods of diagnosing and treating preeclampsia
12/27/1996EP0749496A1 Human dna mismatch repair proteins
12/27/1996EP0749494A1 Compositions for the inhibition of tnf formation and uses thereof
12/27/1996EP0749488A1 Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders
12/27/1996EP0749485A1 ANTIMICROBIAL PROTEINS FROM $i(ARALIA) AND $i(IMPATIENS)
12/27/1996EP0749484A1 COORDINATE $i(IN VIVO) GENE EXPRESSION
12/27/1996EP0749481A1 Humanized monoclonal antibodies against human interleukin-4
12/27/1996EP0749478A1 Yeast strains and modified albumins
12/27/1996EP0749477A1 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
12/27/1996EP0749476A1 Mediators of chronic allograft rejection
12/27/1996EP0749475A1 Use of the cytokine ip-10 as an anti-tumor agent
12/27/1996EP0749472A1 Extracorporeal cell culture and transplantation kits
12/27/1996EP0749447A1 Water-soluble dextran fatty acid esters and their use as solubilisers
12/27/1996EP0749445A1 Antibodies which bind the g-csf receptor extracellular domain and methods of treatment
12/27/1996EP0749444A1 Hybrid human/animal factor viii
12/27/1996EP0749442A1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES
12/27/1996EP0749441A1 Expression and purification of cloned human alpha-fetoprotein
12/27/1996EP0749440A1 Method of isolating and purifying a biomacromolecule
12/27/1996EP0749439A1 Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof
12/27/1996EP0749325A1 Bispecific molecules having clinical utilities
12/27/1996EP0749323A1 Methods for modulating t cell unresponsiveness
12/27/1996EP0749322A1 VACUOLATING TOXIN-DEFICIENT $i(H. PYLORI) AND RELATED METHODS
12/27/1996EP0749320A1 Fibrin-specific antibody for use as an antithrombotic agent
12/27/1996EP0749318A1 Method of stimulating hematopoiesis with hemoglobin
12/27/1996EP0749317A1 Therapeutic uses of bactericidal/permeability-increasing protein dimer products
12/27/1996EP0749316A1 Antithrombotic agents
12/27/1996EP0749312A1 $i(DIROFILARIA IMMITIS) Gp29 PROTEINS, NUCLEIC ACID MOLECULES AND USES THEREOF
12/27/1996EP0749305A1 Process for making avermectin/zein compositions
12/27/1996EP0749302A1 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
12/27/1996EP0664833B1 Therapeutic anti-hiv oligonucleotide and pharmaceutical
12/27/1996EP0633784B1 Hepatitis vaccins containing 3-0 deacylated monophosphoryl lipid A
12/27/1996EP0332651B2 Method of isolating ca 125 antigen
12/27/1996CA2253496A1 Adherence gene from helicobacter pylori and polypeptide coded thereby
12/27/1996CA2224721A1 Calpain inhibitors for the treatment of neurodegenerative diseases
12/27/1996CA2224634A1 Prothrombin derivatives
12/27/1996CA2224253A1 Chitin hydrogels, methods of their production and use
12/27/1996CA2224229A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells
12/27/1996CA2223749A1 Stable tpo-containing lyophilized compositions
12/27/1996CA2222430A1 Methods and compositions for stimulating neurite growth
12/27/1996CA2221567A1 Factor ix binding peptides, derived from factor viii and their use as inhibitors of blood coagulation
12/25/1996CN1138865A Peptides and methods against psoriasis
12/25/1996CN1138864A New compsn. of glycoprotein isoforms having follicle stimulating
12/25/1996CN1138863A Chimeric proteins which block complement activation
12/25/1996CN1138483A Fibre proteinogen compound and its prepn. method
12/24/1996US5587490 Method of inactivation of viral and bacterial blood contaminants
12/24/1996US5587470 3-deazapurines
12/24/1996US5587469 Oligonucleotides containing N-2 substituted purines
12/24/1996US5587468 High affinity nucleic acid ligands to HIV integrase
12/24/1996US5587460 Controller of cell differentiation; immunology
12/24/1996US5587459 Linked to a ligand targeting a cell surface receptor; for treating cancers and autoimmune diseases